Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks

Non-small cell lung cancer (NSCLC) is the prevailing lung cancer type, accounting for ~85% of all lung cancer cases. Despite their initial promise, current chemotherapeutic protocols are reaching their limits. This necessitates the prompt discovery of new molecular drivers and the development of nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Stravopodis, Dimitrios J., Papavassiliou, Kostas A., Papavassiliou, Athanasios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158021/
https://www.ncbi.nlm.nih.gov/pubmed/37151885
http://dx.doi.org/10.7150/ijbs.83574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158021/
https://www.ncbi.nlm.nih.gov/pubmed/37151885
http://dx.doi.org/10.7150/ijbs.83574

Ejemplares similares